{
    "applicationNumber": "BR 11 2020 013201-2",
    "filingDate": "26/12/2018",
    "grantDate": null,
    "title": "NANOPART\u00cdCULA LIP\u00cdDICA, MEDICAMENTO, M\u00c9TODOS PARA EXPRESSAR UM RECEPTOR, PARA PREVENIR OU TRATAR C\u00c2NCER E PARA PRODUZIR UM MEDICAMENTO, USO DA NANOPART\u00cdCULA LIP\u00cdDICA E DO IMUN\u00d3CITO EX VIVO, COMPOSI\u00c7\u00c3O, IMUN\u00d3CITO EX VIVO, E, C\u00c9LULA EX VIVO",
    "nationalPhaseDate": [
        "26/06/2020"
    ],
    "internationalApplication": {
        "pctNumber": "PCT JP2018/047872",
        "pctDate": "26/12/2018",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "JP",
            "priorityNumber": "2017-252616",
            "priorityDate": "27/12/2017"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2598"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2604"
        },
        {
            "code": "15.35",
            "description": "Atualiza\u00e7\u00e3o de informa\u00e7\u00f5es no portal",
            "bulletinNumber ": "2657"
        }
    ],
    "inventors": [
        "SHINOBU KUWAE",
        "SATORU MATSUMOTO"
    ],
    "holders": [
        82909
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 9/127",
        "A61K 48/00",
        "C12N 5/10",
        "A61P 37/04",
        "A61K 47/34",
        "C12N 15/12",
        "A61K 47/42",
        "A61K 47/18",
        "C07K 14/725",
        "C07K 16/28",
        "A61K 47/24",
        "A61K 31/7105",
        "A61K 31/711",
        "A61K 47/28"
    ]
}